Test Code |
Test Name |
Location |
Methodology |
Disease Category |
MRP |
Days |
MGM213
|
Neurofibromatosis (NF1 and NF2) gene analysis |
Bangalore |
Next Generation Sequencing |
Neurology-neurocutaneous |
14000 |
21 |
MGM215
|
Neurofibromatosis type 2 (NF2) gene analysis |
Bangalore |
Next Generation Sequencing |
Neurology-neurocutaneous |
14000 |
21 |
MGM229
|
TSC1 and TSC2 gene analysis |
Bangalore |
Next Generation Sequencing |
Neurology-neurocutaneous |
14000 |
21 |
MGM2520
|
CYP2C19 Clopidogrel resistance (All CPIC alleles) |
Bangalore |
Next Generation Sequencing |
Cardiology |
14000 |
14 |
MGM2571
|
Recurrent pregnancy loss genetic risk assessment panel |
Bangalore |
Next Generation Sequencing |
OBSTETRICS-GYNACOLOGY |
14000 |
23 |
MGM264
|
Cohen's syndrome (VPS13B) gene analysis |
Bangalore |
Next Generation Sequencing |
Rare inherited diseases |
14000 |
21 |
MGM267
|
Pallister Hall syndrome (GLI3) gene analysis |
Bangalore |
Next Generation Sequencing |
Rare inherited diseases |
14000 |
21 |
MGM300
|
GNPTAB gene sequencing |
Bangalore |
Next Generation Sequencing |
Other |
14000 |
21 |
MGM306
|
Haemophilia A (F8) gene analysis (analysis of the F8 inversion is not included) |
Bangalore |
Next Generation Sequencing |
Hematology |
14000 |
21 |
MGM307
|
Haemophilia B (F9) gene analysis |
Bangalore |
Next Generation Sequencing |
Hematology |
14000 |
21 |
MGM342
|
C8orf37 gene sequencing |
Bangalore |
Next Generation Sequencing |
Ophthalmology |
14000 |
21 |
MGM343
|
Wiskott Aldrich syndrome (WAS) gene analysis |
Bangalore |
Next Generation Sequencing |
Hematology |
14000 |
21 |
MGM352
|
Hyper-immunoglobulin E syndrome (DOCK8) gene sequencing |
Bangalore |
Next Generation Sequencing |
Immunology |
14000 |
21 |
MGM384
|
Thrombotic Thrombocytopenic Purpura (ADAMTS13) gene analysis |
Bangalore |
Next Generation Sequencing |
Immunology |
14000 |
21 |
MGM386
|
Hereditary fructose intolerance (ALDOB) gene sequencing |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
|
|